Stocks in News: Gevo, Inc. (NASDAQ:GEVO), Ericsson (NASDAQ:ERIC), Boston Scientific Corporation (NYSE:BSX) | The Cinema Post
Saturday , December 7 2019
Home / Business News / Stocks in News: Gevo, Inc. (NASDAQ:GEVO), Ericsson (NASDAQ:ERIC), Boston Scientific Corporation (NYSE:BSX)

Stocks in News: Gevo, Inc. (NASDAQ:GEVO), Ericsson (NASDAQ:ERIC), Boston Scientific Corporation (NYSE:BSX)

Gevo, Inc. (NASDAQ:GEVO) reported that 1-for-15 Reverse Stock Split. The 1-for-15 reverse stock split will be effective as of the close of business on April 20, 2015 and the Co’s common stock will begin trading on a split-adjusted basis on Tuesday, April 21, 2015. Gevo, Inc. (NASDAQ:GEVO) stock has highest price of $0.1867 in last session, beginning with a price of $0.1849 and reported a decrease of -8.09% to close at $0.17 with a day range of $0.1700-$0.1867. The stock is going forward its 52-week low with 42.08% and moving down from its 52 week high price with -87.28%.

General Comm reported that alliances with Ericsson (NASDAQ:ERIC) to provide fixed and mobile connections to Alaska’s oil producing North Slope. The firm has started construction and installation of its new advanced, high-speed wireless data network, which will include nine sites spanning from Kuparuk to Point Thomson, stretching over 3,738 square miles. The new network will have data download speeds in excess of 30Mbps. The network will have several new LTE sites that provide service to Alaska’s oil producers and its support industry at remote drilling campsites. Shares of Ericsson (NASDAQ:ERIC) traded at $12.54 by surging 0.88% with price volatility of 1.57% for a week and 1.33% for a month. Its beta stands at 1.16 times.

Boston Scientific Corporation (NYSE:BSX) reported that its data in Journal of the American College of Cardiology that confirms the safety and efficacy of its S-ICD System. The study, “Safety and Efficacy of the Totally Subcutaneous Implantable Defibrillator: 2-year Results from a Pooled Analysis of the IDE Study and EFFORTLESS Registry” was led by Dr. Martin Burke, professor of medicine at the University of Chicago. Boston Scientific Corporation (NYSE:BSX) stock reported a loss of -1.14% to close at $18.19. The total market capitalization remained 24.20 Billion, total volume of 9.6 Million shares held in the session was surprisingly higher than its average volume of 11970.56 shares.

Facebook Comments